4518
A. Kuboki et al. / Tetrahedron Letters 49 (2008) 4516–4518
(1H, 13C NMR) for synthetic 420 were identical to those for natural
cleomiscosin C.4
12. Tanaka, H.; Ishihara, M.; Ichino, K.; Ito, K. Chem. Pharm. Bull. 1988, 36, 3833–
3837.
13. Kuboki, A.; Yamamoto, T.; Ohira, S. Chem. Lett. 2003, 32, 420–421.
14. Magdziak, D.; Rodriguez, A. A.; Water, R. W. V. D.; Pettus, T. R. R. Org. Lett. 2002,
4, 285–288.
In summary, a total synthesis of cleomiscosin C (15 steps from
8, 1.9% overall yield) has been achieved as an application of the
regioselective cycloaddition of o-quinone and 2. It is noteworthy
that silyl substituents were useful in avoiding the oxidative
elimination in the IBX-mediated oxidation of phenol for selective
formation of the target o-quinone 6. Further application of the
cycloaddition is currently under way.
15. Ozanne, A.; Pouysegu, L.; Depernet, D.; Francßois, B.; Quideau, S. Org. Lett. 2003,
5, 2903–2906.
16. From 17 with a methoxy substituent adjacent to the phenolic hydroxyl group,
10b was predominantly obtained instead of 1a in 78% yield by oxidative
elimination.14
OMe
OMe
O
OH
O
O
O
IBX
Acknowledgment
+
DMSO
r.t., 0.5 h
The authors thank Mr. Y. Fukuda of Okayama University of
Science for assistance with the NMR measurements.
O
O
O
O
O
O
17
1a
10%
18
78%
References and notes
17. Since cycloaddition of 6c with 2 did not proceed, the TBS substituent (6a) was
used in the procedure.
18. In a preliminary investigation, we found that the target o-quinone 20 was
generated selectively in 59% yield from 19 with no substituent at C-6 of 6d. On
the basis of this result, we initially planned the synthesis using 6d.
1. Kuboki, A.; Yamamoto, T.; Taira, M.; Arishige, T.; Ohira, S. Tetrahedron Lett.
2007, 48, 771–774.
2. Kuboki, A.; Yamamoto, T.; Taira, M.; Arishige, T.; Konishi, R.; Hamabata, M.;
Shirahama, M.; Hiramatsu, T.; Kuyama, K.; Ohira, S. Tetrahedron Lett. 2008, 49,
2558–2561.
3. (a) Bhandari, P.; Pant, P.; Rastogi, R. P. Phytochemistry 1982, 21, 2147–2149; (b)
Mizuno, M.; Kojima, H.; Tanaka, T.; Iinuma, M.; Kimura, R.; Min, Z. D.; Murata,
H. Phytochemistry 1987, 26, 2071–2074; (c) Hemlata; Kalidhar, S. B. J. Indian
Chem. Soc. 1994, 71, 213–214; (d) Cheng, X. F.; Chen, Z. L. Fitoterapia 2000, 71,
341–342; (e) Wu, P.-L.; Chuang, T.-H.; He, C.-X.; Wu, T.-S. Bioorg. Med. Chem.
2004, 12, 2193–2197; (f) Son, Y. K.; Lee, M. H.; Han, Y. Arch. Pharm. Res. 2005,
28, 34–38; (g) Wu, P.-L.; Wu, T.-S.; He, C.-X.; Su, C.-H.; Lee, K.-H. Chem. Pharm.
Bull. 2005, 53, 56–59; (h) Jin, W. Y.; Min, B. S.; Lee, J. P.; Thuong, P. T.; Lee, H.-K.;
Song, K.; Seong, Y. H.; Bae, K. Arch. Pharm. Res. 2007, 30, 172–176.
4. Ray, A. B.; Chattopadhyay, S. K.; Kumar, S.; Konno, C.; Kiso, Y.; Hikino, H.
Tetrahedron 1985, 41, 209–214.
Br
Br
OH
O
O
IBX
DMSO
r.t., 0.5 h
O
O
O
O
19
20
59%
5. Iizuka, T.; Nagumo, E.; Yotsumoto, H.; Moriyama, H.; Nagai, M. Biol. Pharm. Bull.
2007, 30, 1164–1166.
6. Ahmad, V. U.; Ullah, F.; Hussain, J.; Farooq, U.; Zubair, M.; Khan, M. T. H.;
Choudhary, M. I. Chem. Pharm. Bull. 2004, 52, 1458–1461.
7. Yun, B. S.; Lee, I. K.; Ryoo, I. J.; Yoo, I. D. J. Nat. Prod. 2001, 64, 1238–1240.
8. Jin, W. Y.; Thuong, P. T.; Nguyen, D.; Min, B. S.; Son, K. H.; Chang, H. W.; Kim, H.
P.; Kang, S. S.; Sok, D. E.; Bae, K. Arch. Pharm. Res. 2007, 30, 275–281.
9. (a) Lin, L.-J.; Cordell, G. A. J. Chem. Soc., Chem. Commun. 1984, 160–161; (b) Lin,
L.-J.; Cordell, G. A. J. Chem. Res. (S) 1988, 396–397; (c) Lin, L.-J.; Cordell, G. A. J.
Chem. Res. (M) 1988, 3052–3080.
10. Tanaka, H.; Ishihara, M.; Ichino, K.; Ito, K. Heterocycles 1988, 27, 2651–2658.
11. Matsumoto, K.; Takahashi, H.; Miyake, Y.; Fukuyama, Y. Tetrahedron Lett. 1999,
40, 3185–3186.
19. Ishi, H.; Kenmotsu, K.; Döpke, W.; Harayama, T. Chem. Pharm. Bull. 1992, 40,
1770–1772.
20. Spectral data for 4: 1H NMR (400 MHz, DMSO-d6): d 3.30 (ddd, J = 3.4, 4.9,
12.2 Hz, 1H), 3.65 (ddd, J = 2.4, 4.9, 12.2 Hz, 1H), 3.76 (s, 6H), 3.78 (s, 3H), 4.37
(ddd, J = 2.4, 3.4, 7.8 Hz, 1H), 4.95 (d, J = 7.8 Hz, 1H), 5.09 (t, J = 4.9 Hz, 1H), 6.34
(d, J = 9.3 Hz, 1H), 6.73 (s, 2H), 6.91 (s, 1H), 7.96 (d, J = 9.3 Hz, 1H), 8.60 (s, 1H);
(400 MHz, CDCl3): d 2.18 (dd, J = 4.8, 7.8 Hz, 1H), 3.59 (ddd, J = 3.4, 7.8, 12.2 Hz,
1H), 3.90 (s, 3H), 3.92 (s, 6H), 3.95 (ddd, J = 2.9, 4.8, 12.2 Hz, 1H), 4.11 (ddd,
J = 2.9, 3.4, 8.3 Hz, 1H), 5.04 (d, J = 8.3 Hz, 1H), 5.62 (s, 1H), 6.34 (d, J = 9.8 Hz,
1H), 6.55 (s, 1H), 6.68 (s, 2H), 7.64 (d, J = 9.8 Hz, 1H); 13C NMR (100 MHz,
pyridine-d5): d 56.1, 56.3, 60.8, 77.9, 79.9, 101.0, 106.3, 111.9, 113.8, 126.4,
133.0, 138.4, 139.3, 144.4, 146.3, 149.2, 160.7.